Update on Drug-Repurposing: Is it Useful for Tackling Antimicrobial Resistance?
Authors:
- 1 July 2019
- journal article
- editorial
- Published by Taylor & Francis in Future Microbiology
- Vol. 14 (10) , 829-831
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Repurposing disulfiram for treatment of Staphylococcus aureus infectionsInternational Journal of Antimicrobial Agents, 2019
- Drug repurposing for antimicrobial discoveryNature Microbiology, 2019
- Repurposing Ivacaftor for treatment of Staphylococcus aureus infectionsInternational Journal of Antimicrobial Agents, 2017
- Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experienceInfection, 2017
- Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistanceNature Microbiology, 2017
- Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screenNature Medicine, 2016
- More cuts loom for US scienceNature, 2013
- A high-throughput drug screen for Entamoeba histolytica identifies a new lead and targetNature Medicine, 2012
- Update on field use of the available drugs for the chemotherapy of human African trypanosomiasisParasitology, 2012
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004